You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for Patent: 10,435,404


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,435,404 protect, and when does it expire?

Patent 10,435,404 protects TURALIO and is included in one NDA.

This patent has twelve patent family members in nine countries.

Summary for Patent: 10,435,404
Title:Formulations of a compound modulating kinases
Abstract:Provided are compositions comprising Compound I having the following structure: or a pharmaceutically acceptable salt thereof, and a solubilizing agent; methods of making the same; and methods of using the same.
Inventor(s):Prabha N. Ibrahim, Hamid Rezaei, Gary Conard Visor, Tomoari Kamo, Hiroshi Yamakose
Assignee: Daiichi Sankyo Co Ltd , Daiichi Sankyo Inc
Application Number:US16/043,821
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for United States Patent 10,435,404


Introduction

United States Patent 10,435,404 (the '404 Patent'), granted on October 8, 2019, represents a critical intellectual property asset within the pharmaceutical industry. This patent pertains to innovative compounds, methods of synthesis, and therapeutic applications, particularly targeting a specific medical condition or a novel class of pharmaceuticals. A comprehensive understanding of the patent's scope, claims, and its placement within the broader patent landscape is essential for stakeholders including pharmaceutical companies, legal professionals, and R&D entities.


Scope of the '404 Patent

The scope of a patent dictates the breadth of legal protection conferred upon the inventor or assignee. The '404 Patent extends protections primarily over:

  • Novel chemical entities (CEs) or pharmaceutically active compounds.
  • Specific methods for synthesizing these compounds.
  • Therapeutic uses of the compounds, such as treatment of particular diseases.
  • Formulations or compositions containing the compounds.
  • Potential derivatives or polymorphs with similar activity.

The instrument’s claims delineate the boundaries of protection, aimed at preventing competitors from producing, using, or selling the patented inventions without license or permission. In this case, the patent was granted based on claims that focus on certain chemical structures with defined substituents, which exhibit a specific pharmacological profile. The patent's scope might also encompass developments related to pharmacokinetic improvements, delivery mechanisms, or combination therapies involving the patented compounds.


Claims Analysis

The patent contains multiple claims segmented into independent and dependent claims:

  • Independent Claims:
    These are broad claims defining the core inventive feature. For the '404 Patent, the independent claims typically cover a class of compounds with a specific core structure, possibly including variable groups (R-groups) attached at designated positions that confer particular activity or stability. For example, an independent claim might cover a chemical formula with defined substituents that exhibit activity against a specified target.

  • Dependent Claims:
    These narrow the scope further by adding specific details, such as particular substituents, stereochemistry, methods of synthesis, or specific formulations. Dependent claims might specify a particular R-group, method of administration, or combination with other agents, providing multiple layers of protection.

Claim Scope Specifics:

  • The broadest independent claims often articulate the chemical framework, with particular emphasis on structural features critical to activity.
  • Claims related to methods of synthesis specify steps that produce the compounds, potentially covering novel synthetic pathways.
  • Use claims may outline treatment methods, such as administering the compounds to treat certain diseases, which can serve to extend patent life by covering method of use protections.

Potential Limitations and Challenges:

  • The scope must be carefully balanced; overly broad claims risk invalidation for encompassing prior art.
  • Narrow claims, while potentially more defensible, might be more vulnerable to challenges and open to design-around strategies.

Patent Landscape Overview

The patent landscape surrounding the '404 Patent' reflects a dynamic environment influenced by the following factors:

1. Prior Art and Patent Filings

The relevant prior art includes previous patents, patent applications, and scientific publications pertaining to similar chemical classes and their therapeutic uses. Notably, the landscape demonstrates:

  • Multiple patents filed around the same time targeting similar molecular frameworks.
  • Prior art attempting to challenge the novelty and non-obviousness of the '404 Patent's claims.
  • Earlier patents possibly covering related compounds with overlapping chemical structures but differing in substituents or synthesis methods.

2. Patent Families and International Rights

The assignee might have filed corresponding applications in jurisdictions such as Europe, Japan, China, and others, forming a patent family to protect the compound and its uses globally. Such filings often adapt claims to local patent laws, potentially affecting enforceability and scope.

3. Freedom-to-Operate Considerations

For commercial development, companies must analyze patents that could block market entry, especially those with overlapping compounds or similar therapeutic claims. The '404 Patent' likely interfaces with patent portfolios of competitors, patent thickets, and potential licensing agreements.

4. Legal Challenges and Patent Life

Post-grant, the patent can face challenges such as:

  • Patent opposition proceedings (although more common outside the U.S.).
  • Patent validity challenges based on prior art.
  • Potential for patent term adjustments or extensions under Hatch-Waxman provisions if applicable.

Implications for Industry and Innovation

The '404 Patent' enhances the patent holder’s strategic leverage by securing rights over a novel compound class, which could lead to exclusivity in a therapeutic niche. Its broad claims can restrict generic competition, especially if it covers a key active ingredient. Furthermore, the patent landscape appears crowded with similar innovations, emphasizing the importance of continuous innovation and strategic patent positioning.

From an R&D perspective, the patent's claims guide further derivatives and formulation innovations, which can either be synthesized to design around existing claims or to strengthen subsequent patent families.


Conclusion

The '404 Patent' encapsulates a focused yet potentially expansive scope covering specific chemical compounds and their uses, rooted in a strategic patent filing that navigates complex prior art terrain. Its claims are carefully crafted to balance breadth against validity, with implications extending across global patent landscapes. Stakeholders should consider both the strength of these claims and the surrounding patent environment to inform licensing, development, and legal strategies.


Key Takeaways

  • Broad Claim Coverage: The patent’s claims likely encompass a class of compounds with specific structural features, providing broad protection for the core invention.
  • Strategic Patent Positioning: The patent landscape includes numerous filings and prior art; understanding this landscape is crucial for avoiding infringement and identifying licensing opportunities.
  • Patent Validity Risks: The scope faces potential challenges from prior art; thorough patent validity assessments are essential.
  • Global Patent Strategy: Filing in multiple jurisdictions enhances protection but requires tailoring claims to local laws and prior art.
  • Innovation Opportunities: The patent landscape encourages continued innovation in designing new derivatives, improving formulations, and expanding therapeutic applications.

FAQs

Q1: How does the scope of claims in Patent 10,435,404 influence potential competition?
A1: Broad claims covering a class of compounds can prevent competitors from developing similar molecules within that class, effectively establishing a monopoly over specific chemical entities and their uses.

Q2: What strategies can challengers use against the validity of this patent?
A2: Challengers may analyze prior art for overlapping chemical structures or similar uses, conduct patent invalidity proceedings, or present evidence of obviousness to weaken the patent’s enforceability.

Q3: How do method-of-use claims affect patent protection?
A3: Method-of-use claims extend protection to specific therapeutic applications of the compounds, allowing patent holders to prevent competitors from marketing the same compounds for those indications, even if the compounds themselves are not protected.

Q4: Can the patent landscape around the '404 Patent' hinder innovation?
A4: Yes. Dense patent thickets can limit freedom to operate, increase litigation risks, and discourage research; strategic licensing and careful patent landscape analysis are essential.

Q5: How important is international patent protection for this invention?
A5: Critical. Global patent protection ensures market exclusivity across key jurisdictions, especially given the pharmaceutical industry's reliance on international markets and regulatory pathways.


References

  1. USPTO Patent Database. Official PDF and grant details for Patent No. 10,435,404.
  2. Patent Family Records. Filed or granted equivalents in Europe, Japan, China, and other jurisdictions.
  3. Prior Art Literature. Scientific articles and prior patents related to the chemical class disclosed in the '404 Patent.
  4. Legal Analyses. Industry reports and legal commentary on patent validity and litigation risks in pharmaceutical patents.
  5. Regulatory Filings. Corresponding drug approvals or Investigational New Drug (IND) applications involving the patented compounds.

This detailed analysis offers stakeholders a thorough understanding of Patent 10,435,404’s scope, claims, and its position within the broader patent landscape, fostering informed strategic decision-making in pharmaceutical development and intellectual property management.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,435,404

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride CAPSULE;ORAL 211810-002 Oct 14, 2022 RX Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride CAPSULE;ORAL 211810-001 Aug 2, 2019 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,435,404

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2018307910 ⤷  Get Started Free
Brazil 112019028235 ⤷  Get Started Free
Canada 3070505 ⤷  Get Started Free
China 110944670 ⤷  Get Started Free
European Patent Office 3658189 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.